Skip to content
Screener

Kalaris Therapeutics KLRS Q1 2025 earnings

Reported May 14, 2025 · Before market open

EPS-$2.52Miss by $1.74
EPS estimate-$0.78

Next report

Nov 11, 2026 (in 2 months)
EPS estimate-$0.52

Financials

Q1 2025

Income statement

See full
Operating income-$10.4M-304%
Net income-$10.2M-199%
EPS (diluted)-$2.52+3.1%

Balance sheet

See full
Cash & equivalents$101.0M+1,832%
Total equity$63.9M+234%
Total assets$103.1M-28.5%

Cash flow

See full
Operating cash flow-$7.4M-64.6%

FAQ

When did Kalaris Therapeutics report Q1 2025 earnings?
Kalaris Therapeutics (KLRS) reported Q1 2025 earnings on May 14, 2025 before market open.
What were Kalaris Therapeutics's Q1 2025 revenue and EPS?
Kalaris Therapeutics reported eps of $-2.52 for Q1 2025.
Did Kalaris Therapeutics beat estimates in Q1 2025?
EPS missed the consensus estimate of $-0.78 by $1.74.
Where can I find Kalaris Therapeutics's Q1 2025 SEC filings?
You can read the 8-K earnings release (0001193125-25-119408) and the 10-Q periodic report (0000950170-25-071339) directly on SEC EDGAR. The filing index links above go to sec.gov.